Pharmaceutical Validation Consulting in the UAE
Pharmaceutical manufacturers and distributors across the UAE turn to PHARPRO for CSV validation, QA gap assessments, CQV, thermal mapping and GMP training, delivered on-site or remotely and built around MoHAP, HAAD and DHA expectations.
Understanding the UAE Pharmaceutical Landscape
The UAE pharmaceutical sector is one of the fastest-growing in the MENA region, with over 30 licensed manufacturers and a rapidly expanding wholesale and distribution network. MoHAP aligns closely with ICH and PIC/S guidelines, meaning pharmaceutical companies in the UAE face the same regulatory rigour as European and US markets.
PHARPRO has worked with pharmaceutical clients across United Arab Emirates - both remotely and on-site - delivering CSV validation, QA support, and GMP training that meets the regulatory expectations your team faces.
Compliance Services for UAE Pharma
Remote and on-site support, delivered at the pace your programme requires.
CSV Validation
Full-lifecycle CSV for pharma software and laboratory systems. IQ/OQ/PQ, URS, risk classification, and audit trail review - aligned with EU GMP Annex 11 and FDA 21 CFR Part 11.
QA & Gap Assessment
Gap assessments against UAE Ministry of Health & Prevention (MoHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA) and international GMP standards. SOP reviews, CAPA management, and data integrity programmes.
CQV & Thermal Mapping
Equipment and utility qualification (IQ/OQ/PQ) and temperature mapping studies for UAE pharmaceutical warehouses, cold chain facilities, and manufacturing areas.
GMP Training
Customised GMP training for UAE pharma teams - data integrity, CSV fundamentals, IQ/OQ/PQ methodology, and inspection readiness.
Inspection Readiness
Mock audits and gap assessments to prepare your UAE site for UAE Ministry of Health & Prevention (MoHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA) inspections and international authority audits.
CAPA Management
Root cause analysis, corrective and preventive action planning, and CAPA effectiveness checks - aligned with ICH Q10 and GMP requirements.
Regulations We Work Within in UAE
All PHARPRO work in United Arab Emirates is aligned with applicable local and international regulatory standards.
Frequently Asked Questions - UAE
Yes — PHARPRO has an active track record with pharmaceutical manufacturers, distributors and contract organisations across the UAE, supporting CSV validation, QA gap assessments, GMP training and inspection readiness on both a remote and on-site basis.
Pharmaceutical companies in United Arab Emirates must comply with UAE Ministry of Health & Prevention (MoHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA) requirements. Export-focused manufacturers must additionally comply with the regulatory requirements of their target markets.
Yes — most UAE engagements run remotely: CSV documentation, QA assessments and training all translate well to a distributed workflow. When a project calls for hands-on work such as thermal mapping or a mock inspection, Mohammad Awawdeh travels to the site, and many UAE clients run a blended remote/on-site model.
PHARPRO can usually start remote work within 3-5 business days for urgent situations like an imminent inspection. Planned UAE projects typically kick off 1-2 weeks after the proposal is agreed.
Ready to start your UAE compliance project?
Start with a free 30-minute compliance assessment. No commitment, no sales pitch.
الخدمات في الإمارات